 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/16/2024 |
$196.20 |
$197.73 |
$194.94 |
$195.15 |
871.90K | | 04/17/2024 |
$196.36 |
$196.36 |
$192.01 |
$192.16 |
1.32M | | 04/18/2024 |
$191.75 |
$192.56 |
$189.52 |
$190.52 |
1.51M | | 04/19/2024 |
$190.72 |
$194.53 |
$189.44 |
$194.38 |
1.60M | | 04/22/2024 |
$196.19 |
$196.78 |
$193.23 |
$194.11 |
1.12M |
|
|
| Biogen is a biopharmaceutical company focused on discovering, developing and delivering therapies for neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Co. has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Co. also commercialize biosimilars of biologics and focuses on improving its pipeline in neuroscience and immunology. Co.'s marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; ADUHELM for the treatment of Alzheimer's disease; and FUMADERM for the treatment of severe plaque psoriasis. | |
|
Biogen (BIIB) has the following price history information. Looking back at BIIB historical stock prices for the last five trading days, on April 16, 2024, BIIB opened at $196.20, traded as high as $197.73 and as low as $194.94, and closed at $195.15. Trading volume was a total of 871.90K shares. On April 17, 2024, BIIB opened at $196.36, traded as high as $196.36 and as low as $192.01, and closed at $192.16. Trading volume was a total of 1.32M shares. On April 18, 2024, BIIB opened at $191.75, traded as high as $192.56 and as low as $189.52, and closed at $190.52. Trading volume was a total of 1.51M shares. On April 19, 2024, BIIB opened at $190.72, traded as high as $194.53 and as low as $189.44, and closed at $194.38. Trading volume was a total of 1.60M shares. On April 22, 2024, BIIB opened at $196.19, traded as high as $196.78 and as low as $193.23, and closed at $194.11. Trading volume was a total of 1.12M shares.
BIIB Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biogen shares, starting with a $10,000 purchase of BIIB, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/24/2014 |
|
| End date: |
04/22/2024 |
|
| Start price/share: |
$294.84 |
|
| End price/share: |
$194.11 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-34.16% |
|
| Average Annual Total Return: |
-4.09% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6,585.51 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/16/2024 | $195.15 | | 04/17/2024 | $192.16 | | 04/18/2024 | $190.52 | | 04/19/2024 | $194.38 | | 04/22/2024 | $194.11 |
|
|
Free BIIB Email Alerts:
